Anti-Infective Prophylaxis, Immunization and Prevention of Recurrent Infectious Complications in Long-Term Survivors

Keyphrases

• Graft-versus-host Disease (GvHD) 100%
• Infection Risk 100%
• Infectious Complications 100%
• Immunization 100%
• Hematopoietic Stem Cell Transplantation 100%
• Long-term Survivors 100%
• Anti-infective 100%
• Childhood Diseases 50%
• Immune System 50%
• Immunosuppressive Therapy 50%
• Survivors 50%
• Viral Infection 50%
• Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) 50%
• Respiratory Viruses 50%
• Cytomegalovirus 50%
• Cellular Immunity 50%
• Preemptive Treatment 50%
• Prophylaxis Treatment 50%
• Immune Reconstitution 50%
• Immune Deficiency 50%
• Opportunistic Infections 50%
• Streptococcus Pneumoniae 50%
• Haemophilus Influenzae 50%
• Pneumocystis Jirovecii 50%
• Humoral Immunity 50%
• Encapsulated Bacteria 50%
• Seasonal Influenza Vaccine 50%
• Aspergillus Spp 50%
• Fungal Pneumonia 50%
• Long-term Hematopoietic Stem Cell 50%

Medicine and Dentistry

• Hematopoietic Stem Cell Transplantation 100%
• Infection 100%
• Chronic Graft Versus Host Disease 100%
• Infectious Complication 100%
• Immunosuppressive Treatment 50%
• Aspergillus 50%
• Immune Deficiency 50%
• Virus Infection 50%
• Cytomegalovirus 50%
• Opportunistic Infection 50%
• Cellular Immunity 50%
• Immune Reconstitution 50%
• Haemophilus influenzae 50%
• Allogeneic Hematopoietic Stem Cell Transplantation 50%
• Pneumococcal Pneumonia 50%
• Fungal Pneumonia 50%
• Pneumocystis Jirovecii 50%
• Pathogen 50%
• Immune System 50%
• Virus 50%
• Humoral Immunity 50%
• Influenza Vaccine 50%
• Streptococcus Pneumonia 50%
• Diseases 50%

Immunology and Microbiology

• Chronic Graft Versus Host Disease 100%
• Hematopoietic Stem Cell Transplantation 100%
• Adoptive Immunity 50%
• Immunosuppressive Therapy 50%
• Humoral Immunity 50%
• Immune System 50%
• Viral Disease 50%
• Immunodeficiency 50%
• Infectious Agent 50%
• Respiratory Virus 50%
• Influenza Vaccine 50%
• Cytomegalovirus 50%
• Haemophilus influenzae 50%
• Aspergillus 50%
• Immune Reconstitution 50%
• Allogeneic Hematopoietic Stem Cell Transplantation 50%
• Pneumocystis Jiroveci 50%
• Opportunistic Infection 50%
• Streptococcus Pneumonia 50%